rs63750828

Variant summary

Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PS3PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000251.3(MSH2):​c.998G>A​(p.Cys333Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000211169: Published functional studies demonstrate a damaging effect: increased protein turnover with reduced steady-state protein levels, loss of interaction with the MSH3 protein, and decreased MMR efficiency (Ollila et al., 2006" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C333F) has been classified as Likely pathogenic. The gene MSH2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 32)

Consequence

MSH2
NM_000251.3 missense

Scores

15
3

Clinical Significance

Pathogenic reviewed by expert panel P:16O:1

Conservation

PhyloP100: 9.81

Publications

25 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 22 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000211169: Published functional studies demonstrate a damaging effect: increased protein turnover with reduced steady-state protein levels, loss of interaction with the MSH3 protein, and decreased MMR efficiency (Ollila et al., 2006; Gammie et al., 2007; Arlow et al., 2013; Houlleberghs et al., 2016); SCV000592484: Functional characterization of MSH2 missense variant p.Cys333Tyr showed loss of interaction with all partners (Gammie 2007).; SCV000275379: "In vitro functional studies showed normal MSH6 interaction but reduced mismatch repair efficiency compared to the wild-type (7.0% versus 44.7%) and decreased protein stability (Ollila S et al. Gastroenterology. 2006 Nov;131(5):1408-17; Nielsen S et al. PLoS Genet. 2017 04;13(4):e1006739). Additional functional studies have shown p.C333Y to result in loss of mismatch repair activity, decreased MSH2 levels (1% of wild type) and loss of subunit interaction (Gammie AE et al. Genetics. 2007 Oct;177(2):707-21). This alteration was also found to be pathogenic by a functional screening method utilizing oligo targeting mutagenesis and analysis of cell colonies resistant to methylation (Houlleberghs H et al. Proc. Natl. Acad. Sci. U.S.A. 2016 Apr;113(15):4128-33)."; SCV000685148: Functional studies have shown that this variant disrupts MSH2 protein function, decreasing protein stability and expression and resulting in defective mismatch repair (PMID: 17101317, 17720936, 18951462, 23248292, 26951660, 28422960, 33357406).; SCV000751109: Experimental studies have shown that this missense change affects MSH2 function (PMID: 17101317, 17720936, 18951462, 26951660).
PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 16 benign, 33 uncertain in NM_000251.3
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-47416351-G-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 638846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.977
PP5
Variant 2-47416351-G-A is Pathogenic according to our data. Variant chr2-47416351-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 91273.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.998G>Ap.Cys333Tyr
missense
Exon 6 of 16NP_000242.1P43246-1
MSH2
NM_001406674.1
c.998G>Ap.Cys333Tyr
missense
Exon 6 of 18NP_001393603.1
MSH2
NM_001406631.1
c.998G>Ap.Cys333Tyr
missense
Exon 6 of 18NP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.998G>Ap.Cys333Tyr
missense
Exon 6 of 16ENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.998G>Ap.Cys333Tyr
missense
Exon 6 of 16ENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.1049G>Ap.Cys350Tyr
missense
Exon 7 of 17ENSP00000588166.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
29
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000590
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
6
-
-
not provided (6)
5
-
-
Lynch syndrome 1 (5)
3
-
-
Hereditary cancer-predisposing syndrome (3)
1
-
-
Hereditary nonpolyposis colon cancer (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
-
Lynch syndrome 1;C5399763:Mismatch repair cancer syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.93
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.96
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.5
H
PhyloP100
9.8
PrimateAI
Pathogenic
0.91
D
PROVEAN
Pathogenic
-10
D
REVEL
Pathogenic
0.95
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.96
MPC
0.027
ClinPred
1.0
D
GERP RS
5.6
Varity_R
0.99
gMVP
0.80
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs63750828; hg19: chr2-47643490; COSMIC: COSV51881721; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.